Physician profile
Solomon Wolff
NPI 1457137929
$745.42
in general payments reported to CMS, 2019-2025
20 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $269 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $92.73 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $90.30 | 2024-2025 | Airsupra, Farxiga |
| Pfizer INC. | $81.57 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $52.49 | 2024-2025 | |
| Amgen INC. | $46.95 | 2024-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $43.55 | 2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.36 | 2024-2025 | Ofev |
| Viatris Specialty LLC | $40.59 | 2025 | Yupelri |
| Eisai INC. | $37.63 | 2024-2025 | |
| Mylan Specialty L.P. | $25.54 | 2024 | Yupelri |
| Verona Pharma, INC. | $23.07 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $21.94 | 2025 | |
| Inspire Medical Systems, INC. | $20.45 | 2025 | Inspire |
| Exact Sciences Corporation | $20.00 | 2024 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $19.33 | 2025 | Nexletol |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.20 | 2024 | Mounjaro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.07 | 2025 | Xifaxan |
| Abbott Laboratories | $18.90 | 2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.89 | 2024 | Caplyta |
| Axsome Therapeutics, INC. | $12.86 | 2025 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solomon Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.